Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum
Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of...
Gespeichert in:
Veröffentlicht in: | Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2019-12, Vol.157 (6), p.1572-1583.e8 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1583.e8 |
---|---|
container_issue | 6 |
container_start_page | 1572 |
container_title | Gastroenterology (New York, N.Y. 1943) |
container_volume | 157 |
creator | He, Zhengxiang Chen, Lili Chen, Grace Smaldini, Paola Bongers, Gerold Catalan-Dibene, Jovani Furtado, Glaucia C. Lira, Sergio A. |
description | Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of serrated polyps depends on the composition of the gut microbiota and is associated with bacterial invasion of the lamina propria, accompanied by induction of inflammation and up-regulation of interleukin 1 beta (IL1B) and matrix metalloproteinase (MMP) 3 in the cecum. We investigated the mechanisms by which these changes contribute to development of serrated polyps.
We performed studies with C57BL/6 (control) and HBUS mice. To accelerate polyp development, we increased the exposure of the bacteria to the lamina propria by injecting HBUS mice with diphtheria toxin, which binds transgenic HBEGF expressed by the epithelial cells and causes apoptosis. Mice were given injections of IL1B-neutralizing antibody and the MMP inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid. Intestinal tissues were collected from mice and analyzed by histology, reverse-transcription polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytometry. We examined fibroblast subsets in polyps using single-cell RNA sequencing.
Administration of diphtheria toxin to HBUS mice accelerated development of serrated polyps (95% of treated mice developed polyps before 100 days of age, compared with 53% given vehicle). IL1B stimulated subsets of platelet-derived growth factor receptor alpha+ (PDGRFA+) fibroblasts isolated from cecum, resulting in increased expression of MMP3. Neutralizing antibodies against IL1B or administration of the MMP inhibitor reduced the number of serrated polyps that formed in the HBUS mice. Single-cell RNA sequencing analysis showed subsets of fibroblasts in serrated polyps that express genes that regulate matrix fibroblasts and inflammation.
In studies of mice, we found that barrier breakdown and expression of inflammatory factors contribute to development of serrated polyps. Subsets of cecal PDGFRA+ fibroblasts are activated by release of IL1B from myeloid cells during the early stages of serrated polyp development. MMP3 produced by PDGFRA+ fibroblasts is important for serrated polyp development. Our findings confirm the functions of previously identified serrated polyp–associated molecules and indicate roles for immun |
doi_str_mv | 10.1053/j.gastro.2019.08.025 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2283106221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016508519412456</els_id><sourcerecordid>2283106221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-b4fee55d7ae39bde02f24e9a44863fca80a2dbbcbb3778feb30ee372dd06cb523</originalsourceid><addsrcrecordid>eNp9kcuO1DAQRS0EYpqBP0DISzYJZTvpuDdIqOfBSNMC8VhbflTATRIH2xmYHf_Ait_jS3CrB5asSqU6VfeWLiFPGdQMWvFiX3_SKcdQc2CbGmQNvL1HVqzlsgJg_D5ZlbKuWpDtCXmU0h4ANkKyh-REsKYrXbciv66mjHHA5YufKKMGs6Z6cnSnc_Tf6a70wxBmnLN3OiEVdBumMjJLRpoDPcMbLPMRp0xDT89n7zCOeqCXMXzLn-mFtjlE-g5tORHi7x8_z3DGyR349xijzujo2zDczokWB7uwFJEt2mV8TB70ekj45K6eko8X5x-2r6vrN5dX21fXlW1A5so0PWLbuk6j2BiHwHve4EY3jVyL3moJmjtjrDGi62SPRgCi6LhzsLam5eKUPD_enWP4umDKavTJ4jDoCYsbxbkUDNacs4I2R9TGkFLEXs3RjzreKgbqEIraq2Mo6hCKAqlKKGXt2Z3CYkZ0_5b-plCAl0cAy583HqNK1uNk0fmINisX_P8V_gDJzaRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2283106221</pqid></control><display><type>article</type><title>Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Alma/SFX Local Collection</source><creator>He, Zhengxiang ; Chen, Lili ; Chen, Grace ; Smaldini, Paola ; Bongers, Gerold ; Catalan-Dibene, Jovani ; Furtado, Glaucia C. ; Lira, Sergio A.</creator><creatorcontrib>He, Zhengxiang ; Chen, Lili ; Chen, Grace ; Smaldini, Paola ; Bongers, Gerold ; Catalan-Dibene, Jovani ; Furtado, Glaucia C. ; Lira, Sergio A.</creatorcontrib><description>Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of serrated polyps depends on the composition of the gut microbiota and is associated with bacterial invasion of the lamina propria, accompanied by induction of inflammation and up-regulation of interleukin 1 beta (IL1B) and matrix metalloproteinase (MMP) 3 in the cecum. We investigated the mechanisms by which these changes contribute to development of serrated polyps.
We performed studies with C57BL/6 (control) and HBUS mice. To accelerate polyp development, we increased the exposure of the bacteria to the lamina propria by injecting HBUS mice with diphtheria toxin, which binds transgenic HBEGF expressed by the epithelial cells and causes apoptosis. Mice were given injections of IL1B-neutralizing antibody and the MMP inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid. Intestinal tissues were collected from mice and analyzed by histology, reverse-transcription polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytometry. We examined fibroblast subsets in polyps using single-cell RNA sequencing.
Administration of diphtheria toxin to HBUS mice accelerated development of serrated polyps (95% of treated mice developed polyps before 100 days of age, compared with 53% given vehicle). IL1B stimulated subsets of platelet-derived growth factor receptor alpha+ (PDGRFA+) fibroblasts isolated from cecum, resulting in increased expression of MMP3. Neutralizing antibodies against IL1B or administration of the MMP inhibitor reduced the number of serrated polyps that formed in the HBUS mice. Single-cell RNA sequencing analysis showed subsets of fibroblasts in serrated polyps that express genes that regulate matrix fibroblasts and inflammation.
In studies of mice, we found that barrier breakdown and expression of inflammatory factors contribute to development of serrated polyps. Subsets of cecal PDGFRA+ fibroblasts are activated by release of IL1B from myeloid cells during the early stages of serrated polyp development. MMP3 produced by PDGFRA+ fibroblasts is important for serrated polyp development. Our findings confirm the functions of previously identified serrated polyp–associated molecules and indicate roles for immune and stromal cells in serrated polyp development.
[Display omitted]</description><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><identifier>DOI: 10.1053/j.gastro.2019.08.025</identifier><identifier>PMID: 31470007</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Apoptosis - immunology ; Barrier Breakdown ; Cecum - cytology ; Cecum - immunology ; Cecum - pathology ; Colonic Polyps - immunology ; Cytokine ; Diphtheria Toxin - administration & dosage ; Diphtheria Toxin - immunology ; Disease Models, Animal ; Epithelial Cells - immunology ; Epithelial Cells - pathology ; ErbB Receptors - antagonists & inhibitors ; ErbB Receptors - metabolism ; Fibroblasts - immunology ; Fibroblasts - metabolism ; Gefitinib - pharmacology ; Heparin-binding EGF-like Growth Factor - genetics ; Heparin-binding EGF-like Growth Factor - metabolism ; Humans ; Hydroxamic Acids - pharmacology ; Interleukin-1beta - immunology ; Interleukin-1beta - metabolism ; Intestinal Mucosa - cytology ; Intestinal Mucosa - immunology ; Intestinal Mucosa - pathology ; Matrix Metalloproteinase 3 - immunology ; Matrix Metalloproteinase 3 - metabolism ; Matrix Metalloproteinase Inhibitors - pharmacology ; Mice ; Mice, Transgenic ; Neoplasm ; Receptor, Platelet-Derived Growth Factor alpha - metabolism ; Stroma ; Sulfonamides - pharmacology</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2019-12, Vol.157 (6), p.1572-1583.e8</ispartof><rights>2019 AGA Institute</rights><rights>Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-b4fee55d7ae39bde02f24e9a44863fca80a2dbbcbb3778feb30ee372dd06cb523</citedby><cites>FETCH-LOGICAL-c408t-b4fee55d7ae39bde02f24e9a44863fca80a2dbbcbb3778feb30ee372dd06cb523</cites><orcidid>0000-0002-3187-120X ; 0000-0002-2734-516X ; 0000-0003-2170-7462 ; 0000-0002-8961-859X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.gastro.2019.08.025$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31470007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Zhengxiang</creatorcontrib><creatorcontrib>Chen, Lili</creatorcontrib><creatorcontrib>Chen, Grace</creatorcontrib><creatorcontrib>Smaldini, Paola</creatorcontrib><creatorcontrib>Bongers, Gerold</creatorcontrib><creatorcontrib>Catalan-Dibene, Jovani</creatorcontrib><creatorcontrib>Furtado, Glaucia C.</creatorcontrib><creatorcontrib>Lira, Sergio A.</creatorcontrib><title>Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum</title><title>Gastroenterology (New York, N.Y. 1943)</title><addtitle>Gastroenterology</addtitle><description>Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of serrated polyps depends on the composition of the gut microbiota and is associated with bacterial invasion of the lamina propria, accompanied by induction of inflammation and up-regulation of interleukin 1 beta (IL1B) and matrix metalloproteinase (MMP) 3 in the cecum. We investigated the mechanisms by which these changes contribute to development of serrated polyps.
We performed studies with C57BL/6 (control) and HBUS mice. To accelerate polyp development, we increased the exposure of the bacteria to the lamina propria by injecting HBUS mice with diphtheria toxin, which binds transgenic HBEGF expressed by the epithelial cells and causes apoptosis. Mice were given injections of IL1B-neutralizing antibody and the MMP inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid. Intestinal tissues were collected from mice and analyzed by histology, reverse-transcription polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytometry. We examined fibroblast subsets in polyps using single-cell RNA sequencing.
Administration of diphtheria toxin to HBUS mice accelerated development of serrated polyps (95% of treated mice developed polyps before 100 days of age, compared with 53% given vehicle). IL1B stimulated subsets of platelet-derived growth factor receptor alpha+ (PDGRFA+) fibroblasts isolated from cecum, resulting in increased expression of MMP3. Neutralizing antibodies against IL1B or administration of the MMP inhibitor reduced the number of serrated polyps that formed in the HBUS mice. Single-cell RNA sequencing analysis showed subsets of fibroblasts in serrated polyps that express genes that regulate matrix fibroblasts and inflammation.
In studies of mice, we found that barrier breakdown and expression of inflammatory factors contribute to development of serrated polyps. Subsets of cecal PDGFRA+ fibroblasts are activated by release of IL1B from myeloid cells during the early stages of serrated polyp development. MMP3 produced by PDGFRA+ fibroblasts is important for serrated polyp development. Our findings confirm the functions of previously identified serrated polyp–associated molecules and indicate roles for immune and stromal cells in serrated polyp development.
[Display omitted]</description><subject>Animals</subject><subject>Apoptosis - immunology</subject><subject>Barrier Breakdown</subject><subject>Cecum - cytology</subject><subject>Cecum - immunology</subject><subject>Cecum - pathology</subject><subject>Colonic Polyps - immunology</subject><subject>Cytokine</subject><subject>Diphtheria Toxin - administration & dosage</subject><subject>Diphtheria Toxin - immunology</subject><subject>Disease Models, Animal</subject><subject>Epithelial Cells - immunology</subject><subject>Epithelial Cells - pathology</subject><subject>ErbB Receptors - antagonists & inhibitors</subject><subject>ErbB Receptors - metabolism</subject><subject>Fibroblasts - immunology</subject><subject>Fibroblasts - metabolism</subject><subject>Gefitinib - pharmacology</subject><subject>Heparin-binding EGF-like Growth Factor - genetics</subject><subject>Heparin-binding EGF-like Growth Factor - metabolism</subject><subject>Humans</subject><subject>Hydroxamic Acids - pharmacology</subject><subject>Interleukin-1beta - immunology</subject><subject>Interleukin-1beta - metabolism</subject><subject>Intestinal Mucosa - cytology</subject><subject>Intestinal Mucosa - immunology</subject><subject>Intestinal Mucosa - pathology</subject><subject>Matrix Metalloproteinase 3 - immunology</subject><subject>Matrix Metalloproteinase 3 - metabolism</subject><subject>Matrix Metalloproteinase Inhibitors - pharmacology</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Neoplasm</subject><subject>Receptor, Platelet-Derived Growth Factor alpha - metabolism</subject><subject>Stroma</subject><subject>Sulfonamides - pharmacology</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcuO1DAQRS0EYpqBP0DISzYJZTvpuDdIqOfBSNMC8VhbflTATRIH2xmYHf_Ait_jS3CrB5asSqU6VfeWLiFPGdQMWvFiX3_SKcdQc2CbGmQNvL1HVqzlsgJg_D5ZlbKuWpDtCXmU0h4ANkKyh-REsKYrXbciv66mjHHA5YufKKMGs6Z6cnSnc_Tf6a70wxBmnLN3OiEVdBumMjJLRpoDPcMbLPMRp0xDT89n7zCOeqCXMXzLn-mFtjlE-g5tORHi7x8_z3DGyR349xijzujo2zDczokWB7uwFJEt2mV8TB70ekj45K6eko8X5x-2r6vrN5dX21fXlW1A5so0PWLbuk6j2BiHwHve4EY3jVyL3moJmjtjrDGi62SPRgCi6LhzsLam5eKUPD_enWP4umDKavTJ4jDoCYsbxbkUDNacs4I2R9TGkFLEXs3RjzreKgbqEIraq2Mo6hCKAqlKKGXt2Z3CYkZ0_5b-plCAl0cAy583HqNK1uNk0fmINisX_P8V_gDJzaRQ</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>He, Zhengxiang</creator><creator>Chen, Lili</creator><creator>Chen, Grace</creator><creator>Smaldini, Paola</creator><creator>Bongers, Gerold</creator><creator>Catalan-Dibene, Jovani</creator><creator>Furtado, Glaucia C.</creator><creator>Lira, Sergio A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3187-120X</orcidid><orcidid>https://orcid.org/0000-0002-2734-516X</orcidid><orcidid>https://orcid.org/0000-0003-2170-7462</orcidid><orcidid>https://orcid.org/0000-0002-8961-859X</orcidid></search><sort><creationdate>201912</creationdate><title>Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum</title><author>He, Zhengxiang ; Chen, Lili ; Chen, Grace ; Smaldini, Paola ; Bongers, Gerold ; Catalan-Dibene, Jovani ; Furtado, Glaucia C. ; Lira, Sergio A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-b4fee55d7ae39bde02f24e9a44863fca80a2dbbcbb3778feb30ee372dd06cb523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Apoptosis - immunology</topic><topic>Barrier Breakdown</topic><topic>Cecum - cytology</topic><topic>Cecum - immunology</topic><topic>Cecum - pathology</topic><topic>Colonic Polyps - immunology</topic><topic>Cytokine</topic><topic>Diphtheria Toxin - administration & dosage</topic><topic>Diphtheria Toxin - immunology</topic><topic>Disease Models, Animal</topic><topic>Epithelial Cells - immunology</topic><topic>Epithelial Cells - pathology</topic><topic>ErbB Receptors - antagonists & inhibitors</topic><topic>ErbB Receptors - metabolism</topic><topic>Fibroblasts - immunology</topic><topic>Fibroblasts - metabolism</topic><topic>Gefitinib - pharmacology</topic><topic>Heparin-binding EGF-like Growth Factor - genetics</topic><topic>Heparin-binding EGF-like Growth Factor - metabolism</topic><topic>Humans</topic><topic>Hydroxamic Acids - pharmacology</topic><topic>Interleukin-1beta - immunology</topic><topic>Interleukin-1beta - metabolism</topic><topic>Intestinal Mucosa - cytology</topic><topic>Intestinal Mucosa - immunology</topic><topic>Intestinal Mucosa - pathology</topic><topic>Matrix Metalloproteinase 3 - immunology</topic><topic>Matrix Metalloproteinase 3 - metabolism</topic><topic>Matrix Metalloproteinase Inhibitors - pharmacology</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Neoplasm</topic><topic>Receptor, Platelet-Derived Growth Factor alpha - metabolism</topic><topic>Stroma</topic><topic>Sulfonamides - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Zhengxiang</creatorcontrib><creatorcontrib>Chen, Lili</creatorcontrib><creatorcontrib>Chen, Grace</creatorcontrib><creatorcontrib>Smaldini, Paola</creatorcontrib><creatorcontrib>Bongers, Gerold</creatorcontrib><creatorcontrib>Catalan-Dibene, Jovani</creatorcontrib><creatorcontrib>Furtado, Glaucia C.</creatorcontrib><creatorcontrib>Lira, Sergio A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Zhengxiang</au><au>Chen, Lili</au><au>Chen, Grace</au><au>Smaldini, Paola</au><au>Bongers, Gerold</au><au>Catalan-Dibene, Jovani</au><au>Furtado, Glaucia C.</au><au>Lira, Sergio A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><addtitle>Gastroenterology</addtitle><date>2019-12</date><risdate>2019</risdate><volume>157</volume><issue>6</issue><spage>1572</spage><epage>1583.e8</epage><pages>1572-1583.e8</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><abstract>Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of serrated polyps depends on the composition of the gut microbiota and is associated with bacterial invasion of the lamina propria, accompanied by induction of inflammation and up-regulation of interleukin 1 beta (IL1B) and matrix metalloproteinase (MMP) 3 in the cecum. We investigated the mechanisms by which these changes contribute to development of serrated polyps.
We performed studies with C57BL/6 (control) and HBUS mice. To accelerate polyp development, we increased the exposure of the bacteria to the lamina propria by injecting HBUS mice with diphtheria toxin, which binds transgenic HBEGF expressed by the epithelial cells and causes apoptosis. Mice were given injections of IL1B-neutralizing antibody and the MMP inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid. Intestinal tissues were collected from mice and analyzed by histology, reverse-transcription polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytometry. We examined fibroblast subsets in polyps using single-cell RNA sequencing.
Administration of diphtheria toxin to HBUS mice accelerated development of serrated polyps (95% of treated mice developed polyps before 100 days of age, compared with 53% given vehicle). IL1B stimulated subsets of platelet-derived growth factor receptor alpha+ (PDGRFA+) fibroblasts isolated from cecum, resulting in increased expression of MMP3. Neutralizing antibodies against IL1B or administration of the MMP inhibitor reduced the number of serrated polyps that formed in the HBUS mice. Single-cell RNA sequencing analysis showed subsets of fibroblasts in serrated polyps that express genes that regulate matrix fibroblasts and inflammation.
In studies of mice, we found that barrier breakdown and expression of inflammatory factors contribute to development of serrated polyps. Subsets of cecal PDGFRA+ fibroblasts are activated by release of IL1B from myeloid cells during the early stages of serrated polyp development. MMP3 produced by PDGFRA+ fibroblasts is important for serrated polyp development. Our findings confirm the functions of previously identified serrated polyp–associated molecules and indicate roles for immune and stromal cells in serrated polyp development.
[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31470007</pmid><doi>10.1053/j.gastro.2019.08.025</doi><orcidid>https://orcid.org/0000-0002-3187-120X</orcidid><orcidid>https://orcid.org/0000-0002-2734-516X</orcidid><orcidid>https://orcid.org/0000-0003-2170-7462</orcidid><orcidid>https://orcid.org/0000-0002-8961-859X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0016-5085 |
ispartof | Gastroenterology (New York, N.Y. 1943), 2019-12, Vol.157 (6), p.1572-1583.e8 |
issn | 0016-5085 1528-0012 |
language | eng |
recordid | cdi_proquest_miscellaneous_2283106221 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete; Alma/SFX Local Collection |
subjects | Animals Apoptosis - immunology Barrier Breakdown Cecum - cytology Cecum - immunology Cecum - pathology Colonic Polyps - immunology Cytokine Diphtheria Toxin - administration & dosage Diphtheria Toxin - immunology Disease Models, Animal Epithelial Cells - immunology Epithelial Cells - pathology ErbB Receptors - antagonists & inhibitors ErbB Receptors - metabolism Fibroblasts - immunology Fibroblasts - metabolism Gefitinib - pharmacology Heparin-binding EGF-like Growth Factor - genetics Heparin-binding EGF-like Growth Factor - metabolism Humans Hydroxamic Acids - pharmacology Interleukin-1beta - immunology Interleukin-1beta - metabolism Intestinal Mucosa - cytology Intestinal Mucosa - immunology Intestinal Mucosa - pathology Matrix Metalloproteinase 3 - immunology Matrix Metalloproteinase 3 - metabolism Matrix Metalloproteinase Inhibitors - pharmacology Mice Mice, Transgenic Neoplasm Receptor, Platelet-Derived Growth Factor alpha - metabolism Stroma Sulfonamides - pharmacology |
title | Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T15%3A38%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin%201%20beta%20and%20Matrix%20Metallopeptidase%203%20Contribute%20to%20Development%20of%20Epidermal%20Growth%20Factor%20Receptor%E2%80%93Dependent%20Serrated%20Polyps%20in%20Mouse%20Cecum&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=He,%20Zhengxiang&rft.date=2019-12&rft.volume=157&rft.issue=6&rft.spage=1572&rft.epage=1583.e8&rft.pages=1572-1583.e8&rft.issn=0016-5085&rft.eissn=1528-0012&rft_id=info:doi/10.1053/j.gastro.2019.08.025&rft_dat=%3Cproquest_cross%3E2283106221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2283106221&rft_id=info:pmid/31470007&rft_els_id=S0016508519412456&rfr_iscdi=true |